Bloomage | Briefing, News, Analysis, Research, Data

Bloomage

Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel

Bloomage, founded in January, 2000 and headquartered in Jinan, is a hyaluronic acid R&D manufacturer. The founder is Zhao Yan. Listed on the SSE on November 6, 2019, the company's major shareholders are Huaxi Xinyu Investment Co., Ltd., China Life Chengda (Shanghai) Health Industry Equity Investment Center (LP) and Ningxia Yingrui Wuyuan PE Partnership Enterprise (LP). Rivals that have direct and indirect competition with Bloomage include Well, Boai Nky, Pharm Agra, Mylan, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Biotech

Founded

Jan 2, 2000

HQ location

Shandong, China

Legal name

Bloomage BioTechnology Corporation Limited

Website

http://www.bloomagebio-tech.com/

ir@bloomagebiotech.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Jun 24, 2022 02:14 PM · Healthcare | Financials

Huaxi biological diving fell by more than 11%

Briefing Jun 20, 2022 11:20 AM · Technology | Communication | Healthcare

"Strange fire technology" obtained tens of millions of yuan of angel round financing

In-depth

Healthcare

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Jun 27, 2022 12:38 PM

Briefing Mar 11, 2022 05:49 PM · Technology | Consumer Staples | Healthcare

Shanghai Stock Exchange: this week, we will focus on monitoring delisting risk stocks such as * ST Chengxing and stocks with abnormal continuous decline recently

Briefing Mar 10, 2022 09:18 PM · Healthcare

Polish President: the issue of providing fighters to Ukraine should be jointly decided by NATO countries

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Mar 10, 2022 07:39 AM · Consumer Staples | Financials | Automotive

New products are popular, pension finance plays a characteristic card

Briefing Mar 09, 2022 07:19 PM

Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year

Briefing Feb 25, 2022 07:18 PM · Technology | Consumer Staples | Healthcare

Huaxin securities's recommendation business qualification was approved by the CSRC

Briefing Feb 25, 2022 06:58 PM · Technology | Healthcare | Automotive

Sun paper: the subsidiary plans to acquire 100% equity of Liujing Chengquan with 1.5 billion yuan

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Jan 04, 2022 08:08 PM · Technology | Healthcare

Xinyuan shares: it is proposed to launch the restricted stock incentive plan in 2022

Briefing Jan 04, 2022 09:29 AM · Consumer Staples | Financials

Financing customers favor 7 shares, and the purchase of joint test technology accounts for 40.65%

Briefing Dec 21, 2021 08:48 AM · Consumer Staples | Financials

CITIC Securities: it is recommended to pay attention to the allocation value of the banking sector after the LPR adjustment boots are implemented

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

In-depth

The cosmetics market is booming in China. Image credit: Christin Hume/Unsplash

Healthcare

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.

Jun 28, 2020 08:35 AM

Briefing Dec 09, 2021 10:39 AM

Baijiu plate strength, mouth cellar line exceeds 10%

Briefing Dec 08, 2021 06:09 PM · Technology | Healthcare | Financials

Tencent cloud reached strategic cooperation with Shanghai Yitong

Briefing Nov 01, 2021 07:43 PM · Technology | Healthcare | Financials

Jiayuan Technology: granted 1975300 restricted shares to 163 incentive objects

Briefing Oct 29, 2021 11:38 AM

Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.

EqualOcean Analysis